89 related articles for article (PubMed ID: 10806335)
1. Inhibition of binding of lactoferrin to the human promonocyte cell line THP-1 by heparin: the role of cell surface sulphated molecules.
Roşeanu A; Chelu F; Trif M; Motaş C; Brock JH
Biochim Biophys Acta; 2000 Jun; 1475(1):35-8. PubMed ID: 10806335
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.
Legrand D; van Berkel PH; Salmon V; van Veen HA; Slomianny MC; Nuijens JH; Spik G
Biochem J; 1997 Nov; 327 ( Pt 3)(Pt 3):841-6. PubMed ID: 9581564
[TBL] [Abstract][Full Text] [Related]
3. Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line.
Damiens E; El Yazidi I; Mazurier J; Elass-Rochard E; Duthille I; Spik G; Boilly-Marer Y
Eur J Cell Biol; 1998 Dec; 77(4):344-51. PubMed ID: 9930659
[TBL] [Abstract][Full Text] [Related]
4. N-terminal stretch Arg2, Arg3, Arg4 and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA.
van Berkel PH; Geerts ME; van Veen HA; Mericskay M; de Boer HA; Nuijens JH
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):145-51. PubMed ID: 9359845
[TBL] [Abstract][Full Text] [Related]
5. Binding of lactoferrin and transferrin to the human promonocytic cell line U937. Effect on iron uptake and release.
Ismail M; Brock JH
J Biol Chem; 1993 Oct; 268(29):21618-25. PubMed ID: 8408013
[TBL] [Abstract][Full Text] [Related]
6. The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus.
El Yazidi-Belkoura I; Legrand D; Nuijens J; Slomianny MC; van Berkel P; Spik G
Biochim Biophys Acta; 2001 Dec; 1568(3):197-204. PubMed ID: 11786226
[TBL] [Abstract][Full Text] [Related]
7. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity.
Di Biase AM; Pietrantoni A; Tinari A; Siciliano R; Valenti P; Antonini G; Seganti L; Superti F
J Med Virol; 2003 Apr; 69(4):495-502. PubMed ID: 12601757
[TBL] [Abstract][Full Text] [Related]
8. Characterization of [125I]acidic fibroblast growth factor binding to the cloned human fibroblast growth factor receptor, FGF-flg, on NIH 3T3 cell membranes: inhibitory effects of heparin, pertussis toxin and guanine nucleotides.
Jarvis MF; Gessner GW; Martin GE; Jaye M; Ravera MW; Dionne CA
J Pharmacol Exp Ther; 1992 Oct; 263(1):253-63. PubMed ID: 1383494
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.
Elass-Rochard E; Roseanu A; Legrand D; Trif M; Salmon V; Motas C; Montreuil J; Spik G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):839-45. PubMed ID: 8554529
[TBL] [Abstract][Full Text] [Related]
10. Binding characteristics of human lactoferrin to the human monocytic leukemia cell line THP-1 differentiated into macrophages.
Eda S; Kikugawa K; Beppu M
Biol Pharm Bull; 1996 Feb; 19(2):167-75. PubMed ID: 8850300
[TBL] [Abstract][Full Text] [Related]
11. Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate.
Pietrantoni A; Fortuna C; Remoli ME; Ciufolini MG; Superti F
Viruses; 2015 Jan; 7(2):480-95. PubMed ID: 25643293
[TBL] [Abstract][Full Text] [Related]
12. The monocytic receptor for lactoferrin and its involvement in lactoferrin-mediated iron transport.
Birgens HS
Adv Exp Med Biol; 1994; 357():99-109. PubMed ID: 7762450
[TBL] [Abstract][Full Text] [Related]
13. Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor.
Ziere GJ; Kruijt JK; Bijsterbosch MK; van Berkel TJ
Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):289-95. PubMed ID: 8546697
[TBL] [Abstract][Full Text] [Related]
14. Binding of extracellular matrix proteins by animal strains of staphylococcal species.
Styriak I; Lauková A; Fallgren C; Wadström T
Vet Microbiol; 1999 Jun; 67(2):99-112. PubMed ID: 10414365
[TBL] [Abstract][Full Text] [Related]
15. Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.
Pejler G
Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):897-903. PubMed ID: 9003378
[TBL] [Abstract][Full Text] [Related]
16. Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line.
Bi BY; Liu JL; Legrand D; Roche AC; Capron M; Spik G; Mazurier J
Eur J Cell Biol; 1996 Mar; 69(3):288-96. PubMed ID: 8900493
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the glycosaminoglycan-binding region of lactoferrin.
Wu HF; Monroe DM; Church FC
Arch Biochem Biophys; 1995 Feb; 317(1):85-92. PubMed ID: 7872808
[TBL] [Abstract][Full Text] [Related]
18. Characterization of binding of human lactoferrin to pneumococcal surface protein A.
Håkansson A; Roche H; Mirza S; McDaniel LS; Brooks-Walter A; Briles DE
Infect Immun; 2001 May; 69(5):3372-81. PubMed ID: 11292760
[TBL] [Abstract][Full Text] [Related]
19. Uptake of lactoferrin by mononuclear phagocytes inhibits their ability to form hydroxyl radical and protects them from membrane autoperoxidation.
Britigan BE; Serody JS; Hayek MB; Charniga LM; Cohen MS
J Immunol; 1991 Dec; 147(12):4271-7. PubMed ID: 1661314
[TBL] [Abstract][Full Text] [Related]
20. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin.
Mann DM; Romm E; Migliorini M
J Biol Chem; 1994 Sep; 269(38):23661-7. PubMed ID: 8089135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
